Related Experiment Video
Updated: Jun 16, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Regulation of hormonal therapy resistance by cell cycle machinery
Binoj Chandrasekharan Nair1, Ratna K Vadlamudi
1Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Abstract:
Estrogen Receptor (ER) plays a central role in the development and progression of breast cancer. Hormonal therapy substantially improves disease-free survival of ER+ve breast tumors, however acquired resistance to endocrine therapies frequently occur. Emerging data implicate growth factor signaling pathways and their cross talk with ER as major cause of resistance. Both these pathways have been recently shown to use cell cycle machinery as downstream effectors in mediating therapy resistance. Several studies have demonstrated deregulation of cell cycle regulators and their cross talk with ER in therapy resistant tumors. The objective of this article is to review the underlying mechanisms by which tumor cells use cell cycle machinery to override hormonal therapy and to explore cell cycle machinery components as novel therapy targets for overcoming hormonal therapy resistance.
Insights
Estrogen Receptor (ER) positive breast cancer can become resistant to hormonal therapy. This review explores how cell cycle machinery contributes to this resistance and identifies potential new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Estrogen Receptor (ER) is crucial in ER-positive breast cancer development and progression.
- Hormonal therapy improves survival but acquired resistance is common.
- Growth factor signaling pathways and their cross-talk with ER are implicated in resistance.
Purpose of the Study:
- To review mechanisms of cell cycle machinery in hormonal therapy resistance.
- To explore cell cycle components as novel therapeutic targets.
Main Methods:
- Literature review of studies on ER, growth factor signaling, and cell cycle machinery.
- Analysis of cross-talk between these pathways in therapy resistance.
Main Results:
- Cell cycle machinery acts as a downstream effector for growth factor signaling in therapy resistance.
- Deregulation of cell cycle regulators and their cross-talk with ER is observed in resistant tumors.
Conclusions:
- Understanding cell cycle machinery's role is key to overcoming hormonal therapy resistance.
- Targeting cell cycle components offers a promising strategy for resistant ER-positive breast cancer.
Related Concept Videos
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Treatment Resistant Cancers
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System
Negative Regulator Molecules

